Ocular toxicity with the use of Blenrep (Belantamab Mafodotin)
Dr. Mani lectured at the 2022 AAO meeting in San Diego about a new cancer drug to treat multiple myeloma. “Ocular toxicity with the use of Blenrep (Belantamab Mafodotin) – a novel treatment for advanced relapsed and refractory Multiple Myeloma.” She treats many patients who are on novel anti cancer therapies with ocular side effects.
